Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
10.47
-0.40 (-3.68%)
At close: Feb 21, 2025, 4:00 PM
10.66
+0.19 (1.81%)
After-hours: Feb 21, 2025, 7:16 PM EST
Rocket Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
268
Market Cap
1.09B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
RCKT News
- 10 days ago - Rocket Pharma Is A Buy At These Prices With Promising Data - Seeking Alpha
- 6 weeks ago - Top 3 Health Care Stocks That Could Blast Off This Month - Benzinga
- 7 weeks ago - Rocket Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
- 2 months ago - Rocket Pharmaceuticals Stock Soars as Jefferies Initiates Coverage at 'Buy' - Investopedia
- 2 months ago - Rocket Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock - Business Wire
- 2 months ago - Rocket Pharmaceuticals Announces Proposed Public Offering of Common Stock - Business Wire
- 3 months ago - Rocket Pharmaceuticals to Participate in the 7th Annual Evercore HealthCONx Conference - Business Wire
- 3 months ago - Rocket Pharmaceuticals' Gene Therapy Progress Boosts Confidence in Future Developments: Analyst - Benzinga